Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.
cam.issuedOnline | 2021-11-12 | |
datacite.contributor.supervisor | editor: Bowman, Natalie | |
dc.contributor.author | Flamand, Claude | |
dc.contributor.author | Alves Sarmento, Christelle | |
dc.contributor.author | Enfissi, Antoine | |
dc.contributor.author | Bailly, Sarah | |
dc.contributor.author | Beillard, Emmanuel | |
dc.contributor.author | Gaillet, Mélanie | |
dc.contributor.author | Michaud, Céline | |
dc.contributor.author | Servas, Véronique | |
dc.contributor.author | Clement, Nathalie | |
dc.contributor.author | Perilhou, Anaïs | |
dc.contributor.author | Carage, Thierry | |
dc.contributor.author | Musso, Didier | |
dc.contributor.author | Carod, Jean-François | |
dc.contributor.author | Eustache, Stéphanie | |
dc.contributor.author | Tourbillon, Céline | |
dc.contributor.author | Boizon, Elodie | |
dc.contributor.author | James, Samantha | |
dc.contributor.author | Djossou, Félix | |
dc.contributor.author | Salje, Henrik | |
dc.contributor.author | Cauchemez, Simon | |
dc.contributor.author | Rousset, Dominique | |
dc.contributor.orcid | Flamand, Claude [0000-0002-8064-445X] | |
dc.contributor.orcid | Beillard, Emmanuel [0000-0002-2546-7614] | |
dc.contributor.orcid | Michaud, Céline [0000-0001-5410-6298] | |
dc.contributor.orcid | Salje, Henrik [0000-0003-3626-4254] | |
dc.contributor.orcid | Cauchemez, Simon [0000-0001-9186-4549] | |
dc.date.accessioned | 2021-12-22T15:05:19Z | |
dc.date.available | 2021-12-22T15:05:19Z | |
dc.date.issued | 2021-11 | |
dc.date.submitted | 2020-10-12 | |
dc.date.updated | 2021-12-22T15:05:18Z | |
dc.description | Funder: National Research Agency | |
dc.description | Funder: Regional Health Agency of French Guiana | |
dc.description | Funder: Institut Pasteur Urgence COVID-19 fundraising | |
dc.description.abstract | BACKGROUND: While Latin America has been heavily affected by the pandemic, only a few seroprevalence studies have been conducted there during the first epidemic wave in the first half of 2020. METHODOLOGY/PRINCIPAL FINDINGS: A cross-sectional survey was performed between 15 July 2020 and 23 July 2020 among individuals who visited 4 medical laboratories or 5 health centers for routine screening or clinical management, with the exception of symptomatic suggestive cases of covid-19. Samples were screened for the presence of anti-SARS-CoV-2 IgG directed against domain S1 of the SARS-CoV-2 spike protein using the anti-SARS-CoV-2 enzyme-linked immunosorbent assay (ELISA) from Euroimmun. CONCLUSIONS/SIGNIFICANCE: The overall seroprevalence was 15.4% [9.3%-24.4%] among 480 participants, ranging from 4.0% to 25.5% across the different municipalities. The seroprevalence did not differ according to gender (p = 0.19) or age (p = 0.51). Among SARS-CoV-2 positive individuals, we found that 24.6% [11.5%-45.2%] reported symptoms consistent with COVID-19. Our findings revealed high levels of infection across the territory but a low number of resulting deaths, which can be explained by French Guiana's young population structure. | |
dc.identifier.doi | 10.17863/CAM.79136 | |
dc.identifier.eissn | 1935-2735 | |
dc.identifier.issn | 1935-2727 | |
dc.identifier.other | pntd-d-20-01805 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/331686 | |
dc.language | en | |
dc.publisher | Public Library of Science (PLoS) | |
dc.subject | Research Article | |
dc.subject | Biology and life sciences | |
dc.subject | Medicine and health sciences | |
dc.subject | Research and analysis methods | |
dc.title | Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020. | |
dc.type | Article | |
dcterms.dateAccepted | 2021-10-22 | |
prism.issueIdentifier | 11 | |
prism.publicationName | PLoS Negl Trop Dis | |
prism.volume | 15 | |
pubs.funder-project-id | European Regional Development Fund (GY0027257) | |
rioxxterms.licenseref.uri | http://creativecommons.org/licenses/by/4.0/ | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1371/journal.pntd.0009945 |
Files
Original bundle
1 - 3 of 3
No Thumbnail Available
- Name:
- pntd.0009945.xml
- Size:
- 90.46 KB
- Format:
- Extensible Markup Language
- Description:
- Bibliographic metadata
- Licence
- http://creativecommons.org/licenses/by/4.0/
No Thumbnail Available
- Name:
- additional-files.zip
- Size:
- 3.71 MB
- Format:
- ZIP file
- Description:
- Supporting information
- Licence
- http://creativecommons.org/licenses/by/4.0/
No Thumbnail Available
- Name:
- pntd.0009945.pdf
- Size:
- 1.84 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- http://creativecommons.org/licenses/by/4.0/